Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

248 та иш

Иш: siRNA-based strategies to combat drug resistance in gastric cancer

  1. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities

    Ali Hassanzadeh, Heshu Sulaiman Rahman, Alexander Markov +8

    Шарҳ мақола20218 иқтибос
    ABI

  2. A view on drug resistance in cancer

    Neil Vasan, José Baselga, David M. Hyman

    Шарҳ мақола20197 иқтибос
    ABI

  3. Autophagy and autophagy-related proteins in cancer

    Xiaohua Li, Shikun He, Binyun Ma

    Шарҳ мақола20204 иқтибос
    ABI

  4. Genetically-modified Stem Cell in Regenerative Medicine and CancerTherapy; A New Era

    Javad Verdi, Ali Hassanzadeh, Somayeh Shamlou +2

    Шарҳ мақола20214 иқтибос
    ABI

  5. The molecular machinery of regulated cell death

    Daolin Tang, Rui Kang, Tom Vanden Berghe +2

    Шарҳ мақола20194 иқтибос
    ABI

  6. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges

    Chin-Yap Loh, Jian Chai, Ting Tang +5

    Шарҳ мақола20193 иқтибос
    ABI

  7. Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms

    Saleheh Rezapour, Elham Hosseinzadeh, Faroogh Marofi +1

    Шарҳ мақола20193 иқтибос
    ABI

  8. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

    Sayda M. Elbashir, Jens Harborth, Winfried Lendeckel +3

    Мақола20013 иқтибос
    ABI

  9. EMT‐associated microRNAs and their roles in cancer stemness and drug resistance

    Guangtao Pan, Yuhan Liu, Luorui Shang +2

    Шарҳ мақола20213 иқтибос
    ABI

  10. The comprehensive landscape of miR-34a in cancer research

    Sijing Li, Xiaohui Wei, Jinyong He +6

    Шарҳ мақола20213 иқтибос
    ABI

  11. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells

    Peiming Zheng, Lei Chen, Xiangliang Yuan +5

    Мақола20172 иқтибос
    ABI

  12. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer

    Yunfei Zhang, Changsheng Li, Yi Zhou +1

    Мақола20202 иқтибос
    ABI

  13. <p>Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer</p>

    Qiumo Zhang, Haiyang Zhang, Tao Ning +9

    Мақола20202 иқтибос
    ABI

  14. LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer

    Haidong Cheng, Gaowa Sharen, Zhaoyang Wang +1

    Мақола20212 иқтибос
    ABI

  15. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

    Shumin Ouyang, Huaxuan Li, Linlin Lou +17

    Мақола20222 иқтибос
    ABI

  16. Cell death affecting the progression of gastric cancer

    Haoying Wang, Mengxiao Liu, Xi Zeng +3

    Шарҳ мақола20222 иқтибос
    ABI

  17. Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer

    Yifan Lu, Zhijian Jin, Junyi Hou +13

    Мақола20222 иқтибос
    ABI

  18. Silence of URI in gastric cancer cells promotes cisplatin-induced DNA damage and apoptosis.

    Huiqin Bian, Yu Gu, Chen Chen +9

    Мақола20232 иқтибос
    ABI

  19. Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy

    Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref +2

    Мақола20242 иқтибос
    ABI

  20. Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3

    Bibo Tan, Yong Li, Qun Zhao +3

    Мақола20132 иқтибос
    ABI

  21. Therapeutic siRNA: State-of-the-Art and Future Perspectives

    Maik Friedrich, Achim Aigner

    Шарҳ мақола20222 иқтибос
    ABI

  22. Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities

    Houman Isazadeh, Farshid Oruji, Shima Shabani +4

    Шарҳ мақола20232 иқтибос
    ABI

  23. Lnc-SNHG16/miR-128 axis modulates malignant phenotype through WNT/β-catenin pathway in cervical cancer cells

    Wu Wu, Li Guo, Zhenlong Liang +2

    Мақола20202 иқтибос
    ABI

  24. New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses

    Amin Kamrani, Hadi Nasiri, Ali Hassanzadeh +8

    Мақола20242 иқтибос
    ABI

  25. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis

    Jing Yang, Sendurai A. Mani, Joana Liu Donaher +7

    Мақола20042 иқтибос
    ABI